Cafepharma Today

June 6 2025 - Novartis presses court for hasty decision in long-running Entresto patent feud with MSN
Novartis presses court for hasty decision in long-running Entresto patent feud with MSN
'Not a horse and pony show': At FDA cell and gene roundtable, officials look for ways to cut red tape
With ADCs on the rise, drugmakers embrace a new oncology pillar
Bayer trial combines two top drugs for kidney disease
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Gilead: 50% Upside From Here
Seeking Alpha
Saturday, July 19, 2014 - 8:51am
tags:
Gilead Sciences
StemCells, Inc. Announces Closing of $20 Million Offering
Yahoo/Globe Newswire
Saturday, July 19, 2014 - 8:47am
tags:
StemCells
Why the Market is Wrong About Baxter Stock
Motley Fool
Saturday, July 19, 2014 - 8:45am
tags:
Baxter
An Open Letter To Janet Yellen: Is There A Biotech Bubble?
Forbes
Saturday, July 19, 2014 - 8:44am
tags:
Biotech VCs bet $1.8B in a colossal Q2
Fierce Biotech
Saturday, July 19, 2014 - 12:05am
tags:
biotech, venture capital
Arena Stock Rises With Expected Jump In Belviq Sales
Seeking Alpha
Saturday, July 19, 2014 - 12:03am
tags:
Arena Pharmaceuticals, Belviq
Drugmaker Valeant touts Bausch + Lomb growth to Allergan investors
Yahoo/Reuters
Saturday, July 19, 2014 - 12:02am
tags:
Valeant Pharmaceuticals, M&A, Bausch & Lomb, Allergan
AbbVie: Shire Buy More Than Just Taxes
Yahoo/Investors Business Daily
Saturday, July 19, 2014 - 12:01am
tags:
AbbVie, Shire, tax inversions
Will Congress Scuttle the AbbVie-Shire Merger?
FOX Business
Friday, July 18, 2014 - 2:24pm
tags:
US Congress, M&A, AbbVie, Shire
AstraZeneca unveils plans for 'see-through' labs in Cambridge; drug giant hopes layout will encourage collaboration
Telegraph, UK
Friday, July 18, 2014 - 11:58am
tags:
AstraZeneca, R&D
Flu Drug Fighting Resistant Strains to Seek U.S. Approval
Bloomberg
Friday, July 18, 2014 - 11:23am
tags:
FDA, influenza, Medivector, favipiravir, Fujifilm
Sage soars after banking $90M in an up-sized IPO
Fierce Biotech
Friday, July 18, 2014 - 11:20am
tags:
SAGE Therapeutics, CNS, IPOs
Ackman to Allergan shareholders: Valeant's offer won't last forever
Fierce Pharma
Friday, July 18, 2014 - 11:14am
tags:
Allergan, Bill Ackman, Valeant Pharmaceuticals, M&A
Gentiva Gets Alternative Offer After Kindred’s Hostile Bids
Bloomberg
Friday, July 18, 2014 - 11:12am
tags:
Gentiva Health Services, Kindred Healthcare, M&A
[video] Tax implications of AbbVie-Shire
CNBC
Friday, July 18, 2014 - 11:09am
tags:
AbbVie, Shire, M&A, taxes, tax inversions
Northwest Bio And The Curious Relationship With Cognate BioServices
Seeking Alpha
Friday, July 18, 2014 - 10:02am
tags:
Northwest Biotherapeutics, Cognate BioServices
Amgen: Grappling With The Reality Of Patent Expiries
Seeking Alpha
Friday, July 18, 2014 - 9:59am
tags:
Amgen, patents, Neupogen
Stryker's second-quarter profit meets expectations
Yahoo/Reuters
Friday, July 18, 2014 - 8:52am
tags:
Stryker, earnings, devices
Covidien Unveils Advanced Ablation Device for Liver Tumor
Yahoo/Zacks.com
Friday, July 18, 2014 - 8:49am
tags:
Covidien, devices, Emprint Abalation System, liver tumors
AbbVie Seals $54.8 Billion Shire Deal in Booming Tax Migration From U.S.
Bloomberg
Friday, July 18, 2014 - 8:48am
tags:
AbbVie, Shire, taxes, M&A

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.